Oxytocin’s anti-inflammatory and proimmune functions in COVID-19: a transcriptomic signature-based approach

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide pandemic, infecting over 16 million people worldwide with a significant mortality rate. However, there is no current Food and Drug Administration-approved drug that treats coronavirus disease 2019 (COVID-19). Dam...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Physiol Genomics
Huvudupphovsmän: Imami, Ali S., O’Donovan, Sinead M., Creeden, Justin F., Wu, Xiaojun, Eby, Hunter, McCullumsmith, Cheryl B., Uvnäs-Moberg, Kerstin, McCullumsmith, Robert E., Andari, Elissar
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Physiological Society 2020
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7877479/
https://ncbi.nlm.nih.gov/pubmed/32809918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/physiolgenomics.00095.2020
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk